On the Right “Track” with Race Car Driver Charlie Kimball
Charlie Kimball, the first licensed driver with diabetes in the history of the IZOD IndyCar series, will be onsite at Saint Joseph Regional Medical Center, Saturday, May 5th, to speak with children and teens diagnosed with Type 1 diabetes on how he is able to manage his condition.
Beginning at 10:00 am in the Education Center of the SJRMC Mishawaka campus, Kimball will share his story with children and families facing the struggles of diabetes. Today, Kimball continues to prove that though he has diabetes, it does not keep him from driving at speeds of more than 200 miles per hour and fulfilling his dreams. In his presentation, Kimball will remind children and teens that having Type 1 diabetes brings about many challenges, but by learning to take charge of such challenges, theirgoals and dreams are still a reality.
In 2007, Kimball was abruptly forced to abandon his racing program mid-season when he was diagnosed during a routine physician visit. At that time, Kimball was not sure how it would affect his racing. Determined to get back behind the wheel, Kimball worked with his doctors and team to initiate a diabetes treatment plan that included creative precautionary solutions to help him manage his condition while driving. In six short months, Kimball was behind the wheel again claiming a podium finish in his first race back to the circuit.
Kimball has a history of breaking the mold. In 2011, he finished 13th in the famed Indianapolis 500, the world’s largest single-day racing event. In 2005, he became the first American in 13 years to win a British Formula 3 race. He went on to secure two track records and several Formula 3 victories in both Britain and Europe. Kimball has also raced in the Formula 3 Euro Series, the World Series by Renault and the Firestone Indy Light Series.
The SJRMC Education Center is located on the Garden Level of the Saint Joseph Regional Medical Center Mishawaka campus, at 5215 Holy Cross Parkway. Children, teens, families and adults facing challenges relating to Type 1 or Type 2 diabetes are invited to attend.